Tamsulosin Hydrochloride
Product Images NDC 67046-721

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 67046-721). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tam0.4.721

Label for Tamsulosin capsules 0.4 mg, bottle count 30, by Contract Pharmacy Services-PA. The label includes barcodes, lot number, expiration date, and storage conditions. Each capsule contains 0.4 mg of Tamsulosin hydrochloride USP.*

FDA Label Image

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)

A line graph showing mean plasma concentrations of Tamsulosin Hydrochloride (ng/mL) over time (hours) following single-dose administration of 0.4 mg Tamsulosin Hydrochloride capsules under fasted and fed conditions in 8 subjects. The graph compares concentration-time profiles with fasting producing a higher peak concentration than fed conditions.*

FDA Label Image

Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)

A line graph titled 'Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1' showing mean change over weeks of treatment duration for three groups: 0.8 mg, 0.4 mg, and placebo. The x-axis measures treatment duration in weeks from 0 to 13 plus LOCF, and the y-axis shows mean change ranging from 0 to -11. Lines illustrate decreasing symptom scores over time with 0.8 mg showing the greatest reduction, followed by 0.4 mg and placebo.*

FDA Label Image

Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)

A line graph showing the mean change from baseline in total AUA symptom score over a 13-week treatment duration. The graph compares three groups: 0.8 mg dosage, 0.4 mg dosage, and placebo. The y-axis represents mean change, and the x-axis represents treatment duration in weeks, with data points at various intervals including baseline, week 1, 2, 5, 9, and 13 (LOCF). The 0.8 mg and 0.4 mg groups show greater decreases in symptom scores compared to placebo over time.*

FDA Label Image

Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)

A line graph titled 'Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1' showing mean change in urine flow rate over a 13-week treatment period. The x-axis represents duration of treatment in weeks, and the y-axis shows mean change in mL/sec. Three group treatments are compared: 0.8 mg, 0.4 mg, and placebo, with 0.8 mg and 0.4 mg showing higher mean increases than placebo.*

FDA Label Image

Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)

A line graph titled 'Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2,' showing the mean change in urine flow rate over treatment duration in weeks. It compares three treatments: 0.8 mg, 0.4 mg, and placebo, with data points and sample sizes indicated at various weeks up to 13 and last observation carried forward (LOCF).*

FDA Label Image

Chemical Structure (Tamsulosin Str)

Chemical structure of Tamsulosin Hydrochloride, showing the molecular arrangement including aromatic rings, functional groups such as methoxy, sulfonamide, and the hydrochloride moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.